OMECLAMOX-PAK Drug Patent Profile
✉ Email this page to a colleague
When do Omeclamox-pak patents expire, and when can generic versions of Omeclamox-pak launch?
Omeclamox-pak is a drug marketed by Cumberland and is included in one NDA.
The generic ingredient in OMECLAMOX-PAK is amoxicillin; clarithromycin; omeprazole. There are forty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amoxicillin; clarithromycin; omeprazole profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OMECLAMOX-PAK?
- What are the global sales for OMECLAMOX-PAK?
- What is Average Wholesale Price for OMECLAMOX-PAK?
Summary for OMECLAMOX-PAK
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| What excipients (inactive ingredients) are in OMECLAMOX-PAK? | OMECLAMOX-PAK excipients list |
| DailyMed Link: | OMECLAMOX-PAK at DailyMed |
US Patents and Regulatory Information for OMECLAMOX-PAK
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cumberland | OMECLAMOX-PAK | amoxicillin; clarithromycin; omeprazole | CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL | 050824-001 | Feb 8, 2011 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
